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DEFICIENCY OF RDH10 CAUSES CLEFT SECONDARY PALATE IN MOUSE 
Swetha Raja 
November 9, 2017 
The focus of this project is to understand the role of Retinoic Acid (RA) produced 
by RDH10-mediated metabolism of Vitamin A in palate development. For 80 years 
now, we have known that dietary restriction of RA/Vitamin A can cause cleft palate 
but we have failed to understand how RA deficiency causes cleft palate. Our gap 
in knowledge about how RA deficiency causes cleft palate is mainly owing to the 
fact that we lack a model system to study such defects. The aim of this thesis 
research project was to determine if conditional inactivation of the Vitamin A 
metabolic gene Rdh10 in mouse could serve as an experimental model system to 
study the etiology of RA deficient cleft palate in mammals. This study examined a 
mouse model system in which Rdh10 was conditionally inactivated using a 
Tamoxifen-inducible cre-lox system.   At embryonic age 16.5 (E16.5), when palate 
fusion was complete in control embryos, we observed 44% of the Rdh10 
conditional mutant embryos had complete cleft of the secondary palate. 
Histological analysis at E12.5 revealed defects in palate shelf morphology in 
mutant embryos.  Defects at this stage included reduced palate shelf outgrowth 
and a lack of groove between the shelf and the body of the maxilla. We used a 
vi 
 
BrdU assay to label proliferating cells, and identified an increase in cell proliferation 
at the bend region in the mutant embryos compared to controls.  Using a reporter 
mouse strain to detect RA signaling we observed RA signaling within the anterior 
palate shelf tissues. In order to understand if the cleft palate seen in Rdh10 mutant 
embryos was due to defects intrinsic to the palate or if the clefts were secondary 
to abnormalities in development of the mandible or tongue, we isolated and 
cultured maxilla from control and mutant embryos.  We observed that there was 
no significant difference in fusion rate of palate shelves between control and 
mutant maxillae cultured ex vivo.  In summary, these data demonstrate conditional 
inactivation of Rdh10 in mice proves to be an effective experimental model system 
to study how deficiency of RA causes cleft palate. Our findings indicate that RA 
signaling is active in palate tissue and regulates cell proliferation and palate shelf 
morphology. However, we find that the primary defect causing cleft palate in RA 
deficient embryos is not intrinsic to the maxilla. This study opens the door for future 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
1.1 Palate Overview: 
In humans and other mammals, the palate forms a mechanical barrier that 
anatomically separates the oral cavity from the nasal cavity. This enables proper 
breathing and food intake essential for survival. It also plays an important role in 
speech and articulation. Structurally, the palate is formed from two distinct 
components, the primary and the secondary palate. The part of the palate that is 
present anterior to the incisive foramen is the primary palate and the part that is 
present posterior to the incisive foramen is the secondary palate (Fig 1). 
Embryologically, the primary palate is formed from the frontonasal prominence. 
The secondary palate develops from the palatal shelves that arise as medial 
outgrowths of the maxillary process. The secondary palate is structurally 
composed of the hard palate and the muscular soft palate.  
The development of palate is well regulated by genetic and environmental factors. 
Any disturbance during the development process of the palate can result in a major 








Figure 1. Schematic representation of the definitive palate 















1.2 Congenital Birth Defects: 
Congenital anomalies, also known as birth defects, are anatomical abnormalities 
that occur during the development of a fetus.  One in every 33 child born each day 
suffer from a congenital defect, which approximates to 120000 babies each year. 
One in five children die of birth defects. Even infants who survive birth defects often 
face physical, social and psychological challenges (Centers for Disease Control 
and Prevention [CDC] 2014). 
One of the most common craniofacial birth defect known in humans are orofacial 
clefts (Canfield, Honein et al. 2006). Although the incidence of orofacial clefts 
varies across different geographic areas and ethnic groups, one child in every 700 
suffers from some form of orofacial cleft. Orofacial cleft is a broad terminology that 
includes complete midline cleft, cleft lip with or without cleft palate, and cleft of the 
secondary palate.  
We have several systems of classification of orofacial clefts. The one most 
commonly used in clinical scenario is the Veau system. The Veau system classifies 
orofacial cleft into 4 groups based on whether the primary and/or secondary 
palates are affected (Veau V. Division Palatine. 1931) (Table 1). 
For research purposes, we can classify orofacial clefts as syndromic or non-
syndromic clefts. This helps us better understand the functions of genes and other 
factors in the development of craniofacial structures and other organs. Although 
the majority of cleft lip and palate cases are non-syndromic, cleft lip and palate 




valuable to note that cleft palate has been associated with Pierre Robin Syndrome 
(PRS). PRS is characterized clinically by micrognathia, cleft palate and early 
respiratory difficulty caused by glossoptosis. Mouse model of PRS has been 
implicated in several gene mutations such as Sox-9, Sox-11(Benko, Fantes et al. 
2009, Huang, Yang et al. 2016). 
 
Cleft palate poses severe functional limitations, expensive health care cost and 
serious pyscho-social disturbance to children suffering with this defect. Although 
we have improved treatment options available to treat cleft palate, our aim as a 
researcher is to understand how the palate develops and how its development and 
this information can be applied to prevent cleft palate occurrence in the future. One 
of the commonly used tools in developmental biology to understand 
morphogenesis and development is the mouse embryonic model. The mouse 
model closely simulates the development of palate in human embryos. The 





























Veau Classification of Cleft Palate 




1.3 Development of Palate in Mouse:  
 
The development of the secondary palate is a multi-step process that involves cell 
migration, cell differentiation, proliferation, and apoptosis. In mouse embryos, the 
development of the secondary palate can be divided into stages of initiation, 
vertical growth, medial growth and fusion (Bush and Jiang 2012). 
The craniopharyngeal ectoderm and the migratory mesenchymal neural crest cells 
together give rise to the maxillary processes(Ferguson 1988). The mouse palate 
developmental stages mentioned above begin at embryonic stage 10.5 (E10.5), 
identical to the sixth developmental week in humans. At embryonic stage E10.5, 
the bilateral maxillary processes begin to fuse with the medial nasal process to 
give rise to the upper lip and the primary palate (Gritli-Linde 2007). The 
development of the secondary palate begins by E11.5, whereby the growth of the 
palatal shelves is initiated as medial outgrowths of the maxillary processes.(Bush 
and Jiang 2012). This stage is called initiation. The palatal outgrowths then grow 
vertically on either side of the tongue. The next step in palate development is 
elevation. Two models have been proposed as mechanisms for palate elevation. 
The early model suggest that the palatal shelves elevate by a rotating mechanism 
at E14.0 (Ferguson 1988, Gritli-Linde 2007). However, a recent model of palate 
development is gaining popularity. Current understanding of literature says that the 
elevation of palate shelf is rather more complicated than a simple flip up 
mechanism that was widely accepted before. The horizontal palate shelf is formed 
as an outgrowth from the side of the vertical palate shelf rather than the rotation 




grow medially towards the midline and the two palatal shelves on either side 
contact in the midline at E14.5. The anteromedial boundary of the palatal shelves 
fuses with the primary palate. The upper border of the palatal shelves fuse with the 
inferior border of the nasal septum (Kauffman 1992).The medial epithelium seam 
disintegrates (Gritli-Linde 2007), leading to mesenchymal interaction and fusion of 
the palatal shelves.  
Even though, the different steps of palate development were established as early 
as 1924 (Peter 1924), the regulation of these events and the etiology underlying 
cleft palate is still not well understood. The development of the palate is not as 
simple as it seems, but rather complex. It is tightly regulated by genetic and 
environmental factors. The genes and the environmental factors further cause 
intrinsic disruptions within the palate shelf tissues or extrinsic disruptions to 
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DEVELOPMENT OF THE SECONDARY PALATE-MOUSE  
Adapted from 2012, Jeffrey O. Bush and Rulang Jiang 
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Initiation Vertical growth Fusion Medial growth 




1.4 Factors Causing Cleft Palate 
 
1.4.1 Cleft palate caused by intrinsic or extrinsic defects 
 
Cleft palate can occur as a result of defects that occur within the palate shelf 
tissues directly, or by abnormalities of the tongue or mandible that hinder palate 
shelf elevation.  Disturbances that occur within the palate shelf tissue directly are 
known as “intrinsic” defects.  Disturbances that result from primary defects in the 
tongue or mandible that secondarily result in cleft palate are known as “extrinsic” 
defects.   
 
Intrinsic disruptions can affect the initiation, growth, elevation and/or fusion of the 
palate shelf tissue. These disruptions can be caused by both genetic and 
environmental factors.  
 
Extrinsic disruptions can result from abnormalities of the tongue or mandible that 
physically impede the elevation of the palate shelves. During normal palate 
development, the descent of the tongue and growth of the mandible downward 
happens prior to palate shelf elevation. If the mandible fails to grow to make room 
for descent of the tongue, or if the tongue fails to withdraw due to defects in 
myogenesis, then palate shelf elevation can be blocked and cleft  palate can occur. 
It has been published in the literature that mouse mutations in Sox9 or Hoxa2 lead 
to cleft palate due to defective mandibular development, or defects in tongue 
myogenesis, respectively (Gendron-Maguire, Mallo et al. 1993, Bi, Huang et al. 





1.4.2 Cleft palate caused by genetic or environmental factors: 
 
Disturbances in genetic and environmental factors that control palate development 
can cause cleft palate. 
 
Gene mutations in transcription factors, growth factors and signaling molecules 
have been implicated in cleft palate (Rice, Spencer-Dene et al. 2004, Alappat, and 
Zhang et al. 2005). Signaling molecules, such as sonic hedgehog (SHH), 
transforming growth factors (TGF), and fibroblast growth factors (FGF) have been 
shown to be involved in palate development. Alterations and gene mutations in 
these factors have been implicated in cleft palate in mice (Table 2).  
 
In addition to genetic influence on palate development, environmental factors can 
also cause cleft palate. Maternal diet or nutrition are known environmental factors 
that are linked to palate formation. During the development of the fetus, the 
nutritional status of the embryo is dependent on maternal diet, intake, and 
metabolism of food. Maternal diet is crucial particularly during the first trimester 
when major organs such as brain and heart develop. Both excess and deficiency 
of a nutrient could cause craniofacial anomaly. Amongst all nutrients, vitamins are 
of particular importance, as they cannot be synthesized within the body. Vitamins 
play a crucial role during growth and development and hence are considered as a 
vital ingredient of embryonic nutrition. For example, folate deficiency in the mother 











Reference Paper  
Tgfβ3 Intrinsic defective in 
proliferation.  
Primary defect in 
fusion of palatal 
shelves. 
(Kaartinen, Voncken 
et al. 1995, Proetzel, 
Pawlowski et al. 
1995). 
  
Cyp26b1 Intrinsic- Defective 
regulation of fgf10 
(Okano, Kimura et al. 
2012)   
Fgf10 Proliferation defect; 
Increased Apoptosis; 
Defective adhesion 
to other structures. 
(Rice, Spencer-Dene 
et al. 2004, Alappat, 
Zhang et al. 2005)   
Pdgfc Intrinsic: Hypoplasia 




(Ding, Wu et al. 
2004) 
  
Shh Defect in proliferation 
and apoptosis 
(Rice, Spencer-Dene 
et al. 2004)   














1.5 Vitamin A Metabolism: 
Vitamin A is a small lipid soluble molecule that forms one of the most essential 
maternal nutrients. Liver, carrots and other green leafy vegetables have good 
amounts of Vitamin A. Retinoic acid (RA) is the biologically active form of 
Vitamin A.  RA regulates many aspects of embryogenesis (Clagett-Dame and 
Knutson 2011). Hence, knowledge about metabolism of Vitamin A into active RA, 
and how RA regulates embryonic morphogenesis of specific tissues, are needed 
for establishing a fundamental understanding in developmental biology. This 
understanding will prove to be beneficial for future prevention of disease and its 
progression.  
 
Vitamin A is converted into RA by a series of enzymatic reactions. The first step in 
this process involves the conversion of retinol into intermediate product, retinal. 
This conversion is done by two groups of enzymes, the alcohol dehydrogenase 
family (ADH) and the short chain dehydrogenase/ reductase family (SDR). For a 
very long time, due to ubiquitous expression pattern of the ADH family and 
inadequate study techniques, the conversion of retinol to retinal was considered in 
essential for embryogenesis. Recently, RDH10 has been shown to be a critical 
enzyme in the metabolism of Vitamin A into RA (Sandell, Sanderson et al. 2007, 
Sandell, Lynn et al. 2012). Mutants that lack RDH10 cannot metabolize Vitamin A 
and show drastic deficiency in production of RA that affects 
embryogenesis(Metzler and Sandell 2016). Generally, mutants that show 





RA has been known to be regulator of proliferation, differentiation, and apoptosis 
of cells and has a known role in regulating gene expression (Rhinn and Dolle 
2012). RA regulates gene expression by activating nuclear receptors of the retinoic 
acid receptors (RAR) that bind to regulatory DNA elements of target genes (RA 
Response Elements) (Fig 3).  
 
The regulation of endogenous levels of RA is critical for embryo development.  
Both excess RA and insufficient RA result in craniofacial malformations. The 
effects of excessive RA have been well studied using mice lacking 
cytochrome P450 enzymes, which control RA levels by degrading RA, and by 
supplementation of excess RA in maternal diet (Abu-Abed, Dolle et al. 2001, Sakai, 
Tokunaga et al. 2001, Okano, Kimura et al. 2012). In contrast, the effects of 
reduction in normal endogenous levels of RA is incompletely understood and there 



























COOH Retinoic Acid 






Figure3.Vitamin A Metabolism. This figure demonstrates the enzymatic conversion of Vitamin A 
into RA. The first step in this process involves one of the key enzymes in this regulatory pathway, 
RDH10. RDH10 aids in oxidation of retinol into its intermediate, retinal. The next step is the 
conversion of retinal into RA. RA is the active metabolite of Vitamin A and regulates transcription 










1.6 Perturbations of Vitamin A are Associated with Cleft Palate in Humans 
In addition to mouse studies, Vitamin A deficiency or excess has been shown to 
be associated with increased incidence of cleft palate in humans. Epidemiological 
studies have revealed that maternal diets that are low in Vitamin A show higher 
correlation with incidence of orofacial clefts (Krapels, van Rooij et al. 2004). 
Interestingly, dietary intake of rich sources vitamin A, for example liver, reduce the 
risk of cleft (McKinney, Chowchuen et al. 2013). Children born with clefts also have 
reduced serum vitamin A levels (Zhang, Zhou et al. 2014). On the other hand, 
increased consumption of Vitamin A or RA supplements have also shown to be 
associated with orofacial clefts (McKinney, Chowchuen et al. 2013) (Krapels, van 
Rooij et al. 2004).  
 
In summary, both excess and reduced maternal levels of Vitamin A causes cleft 
palate in offspring. Since RA signaling is regulated by the metabolism of a nutrient 
in the diet, we can intervene this signaling pathway for the purpose of prevention 
of cleft palate. The study and understanding of how vitamin A metabolism can be 
intervened to provide therapeutic benefits can be done in animal models and the 






1.7 Focus of My Thesis Project:  
Because Vitamin A and its metabolic products have the potential to influence the 
incidence of orofacial clefts, it is important to understand how vitamin A metabolism 
and RA signaling regulate the development of the secondary palate. Although the 
teratogenic effects of excessive intake of RA have been explored, we have not 
been able to understand the role of deficient RA in the development of cleft palate 
for over 80 years now due to technical difficulties. Dietary models of Vitamin A/RA 
deficiency affect the health of the mother. Complete knock out model of various 
enzymes that aid in the metabolism of Vitamin A have early embryonic death even 
before the initiation of palate development (Lohnes, Mark et al. 1994, Halilagic, 
Ribes et al. 2007). Adding on to the above reasons, we have also not been to 
understand the functions of enzymes that aid in the metabolism of Vitamin A until 
very recently (Sandell, Sanderson et al. 2007). Hence, to date the effects of 
reduced RA in the development of palate remains an unexplored territory in 
developmental biology. 
To resolve this issue and to understand the role of endogenous RA in the 
development of palate, my project at the Sandell lab utilizes a genetic model that 
will allow us to cause RA deficiency in a stage specific manner by conditional 
inactivation of RDH10, a critical enzyme that catalyzes the first step in the 
conversion of Vitamin A into RA. Other lab members have investigated the 
efficiency of tamoxifen induced excision of Rdh10. Rdh10 is excised effectively 
within 48 hours after administration of tamoxifen at either embryological age E7.5 





Using this model system, I would like to answer the following questions:  
1. Is Rdh10 required for development of the secondary palate? 
2. Does RA signaling occur in the palate?  
3. Does RA produced by Rdh10 regulate cell proliferation in the developing 
palatal mesenchyme? 
4. If Rdh10 inactivation causes cleft palate, is the defect due to intrinsic 
mechanism within the palate shelves or extrinsic mechanism due to 
abnormality of the tongue or mandible? 
My thesis focuses on answering these key questions on the role of endogenous 
RA during development of palate.  
Over the course of this study, I have identified that conditional inactivation of 
Rdh10 is an effective model system to study the effects of RA deficiency in 
development of cleft secondary palate. I show that conditional inactivation of 
Rdh10 causes cleft palate in mutant embryos. I show that administration of 
tamoxifen at different gestational stages yields different percentages of cleft palate, 
indicating that Rdh10 function is required at a specific stage of palate development.  
I have demonstrated the presence of RA signaling in the palate at E12.5. In 
addition, I demonstrate that RDH10/RA deficient palates cultured ex vivo without 
the mandible and tongue fuse at the same rate as controls, suggesting that the 





CHAPTER 2: MATERIALS AND METHODS 
2.1 Animals: 
All experiments involving mice were performed in accordance to the protocol that 
was approved by the institutional animal care and use committee (IACUC) at the 
University of Louisville. The approval number for the same is #15190. The day of 
vaginal plug was considered E 0.5.  
The RARE-Lac Z reporter mouse was used to understand the spatiotemporal 
distribution of RA within the palate shelves. These reporter mice were obtained 
from Jackson Laboratories (Official Name: Tg (RARE-Hspa1b/ lacZ) 12Jrt).  
The Rdh10 flox/flox ERT2 Cre mice B6.129-Gt(ROSA)26Sor tm1(cre/ERT2) Tyj/J 
were obtained from the Jackson laboratory (Strain 008463). The Rdh10+/- mice 
lines used in this study were generated and maintained as described previously by 
(Sandell, Sanderson et al. 2007, Sandell, Lynn et al. 2012). 
 
2.2 Generation of Rdh10 Conditional Mutants  
In order to create a timed inactivation of the Rdh10 gene, we crossed Rdh10flox/flox 
Ert2Cre2+/+ with Rdh10+/-. This cross produces embryos of two different genotypes, 
heterozygous Rdh10flox/+ Ert2Cre embryos, which have one wild type copy of 
Rdh10 and serve as controls, and Rdh10flox/- Ert2Cre, which become 




Mutant mice experience Rdh10 inactivation upon activation of the Cre 
recombinase enzyme. Activation of the Cre recombinase was done by 
administration of single dose of Tamoxifen at either E7.5, or E8.5, or E9.5, or 
E10.5.  
After administration of tamoxifen, pregnant mice were euthanized at E16.5 using 
carbon dioxide gas. Following this euthanasia, cervical dislocation was also 
performed to verify that that the animal was deceased before we began dissection. 
Embryos were harvested and decapitated from the body. Harvested embryos were 
transferred to vials containing10Mm PBS (phosphate buffered saline). The vials 
were individually labelled and the tails were sent for genotyping. Embryo heads 
were fixed in 4% paraformaldehyde (PFA) at 40C for 24-48 hours and then 
transferred back to PBS. 
For understanding mechanistic role of Rdh10 deficient cleft palate Embryos were 
harvested at various palate developmental stages (E12.5, E13.5, E14.5, and E15.5 
& E16.5) after administration of tamoxifen at E8.5.  
We administered 5mg Tamoxifen and 1 mg progesterone in 250 µL of corn oil by 
oral gavage to individual pregnant female mice after successful mating. This 
amount of tamoxifen and progesterone was determined empirically.  
2.3 Stain for RARE-Lac Z Reporter Activity: 
RARE-LAC Z reporter mice were used to show RA signaling in the developing 
palate shelves. RARE-lacZ activity was assayed by X-gal staining. For the staining, 




glutaraldehyde for 60 min on ice. Following fixation, specimens were rinsed and 
incubated in Rinse A solution for 30 min at room temperature. The composition of 
Rinse A solution is 5 mM EGTA/2 mM MgCl2/PBS pH 7.3 that was either lab mixed 
or purchased from Millipore. Specimens were then rinsed and incubated in pre 
warmed Rinse B for 15 minutes at 37 °C. Rinse B solution composed of 2 mM 
MgCl2/0.01% Sodium deoxycholate/0.02% NP40/PBS pH 7.3 that was either lab 
mixed or obtained from Millipore. When specimens were fixed, rinsed, and ready 
to be stained, X-gal (Sigma-Aldrich B4252, suspended at 40 mg/ml in Dimethyl 
Formamide) was added to Stain Base Solution to a final concentration of 1 mg/ml. 
Specimens were incubated in stain solution overnight at 37 °C in the dark. After 
staining, specimens were post-fixed in 4% Paraformaldehyde overnight at 4 °C. 
For section staining of RARE lacZ embryos, stained whole mount specimens were 
equilibrated to paraffin using minimal incubation times in neo-clear xylene 
substitute and embedded. After sectioning, slides were de-paraffinized and 
counterstained briefly with Nuclear Fast Red.  
2.4 Whole Mount Nuclear Fluorescent Imaging: 
To analyze morphology of the palate tissue, embryos were collected at embryonic 
stage E16.5 and the mandibles were dissected away to aid in visualizing the palate 
shelves. Embryo morphology was visualized by staining whole embryos with DAPI 
to label all cell nuclei and imaging fluorescent signal. Embryos were fixed in 4% 
formalin overnight at 4oC  and then stained with 2 µg/ml DAPI in PBS, a protocol 
previously described in (Sandell, Kurosaka et al. 2012). Imaging of these embryos 




2.5 Fixation and paraffin embedding of samples: 
In order to do Hematoxylin and Eosin staining for morphological analysis and Brdu 
assay for proliferation, embryo samples were harvested at different stages of 
palate development. Head samples were fixed in 4% Paraformaldehyde (PFA) at 
4°C on a shaker for 24-48 hours (depending on the age of the embryo). Samples 
were then washed in PBS briefly. Samples were then dehydrated through a series 
of graded ethanol (EtOH) (IBI Scientific, Biotechnology grade) at room temperature 
with shaking in the following sequence: washed in 25% EtOH for 30 minutes, then 
50% EtOH for 30 minutes, then 70% EtOH for 30 minutes once. The 70% EtOH 
solution was changed and embryos were left in the solution overnight. Following 
that, samples were then washed in 95% EtOH for 30 minutes once, then 100% 
EtOH for 30 minutes two times. Following ethanol dehydration, the samples were 
washed in neoclear: ethanol mixture at 1:1 ratio for 30 minutes on a rocking 
platform at room temperature. Samples were then immersed in neoclear for 15 
minutes twice. Then, samples were immersed in tissue embedding medium 
(Paraplast Xtra, McCormick Scientific) for 45 minutes. The paraffin was changed 
after 45 minutes and samples were placed in a vacuum chamber for another 45 
minutes. Finally, fixed mouse heads were embedded in an embedding block with 
paraffin wax. Serial frontal sections 8μm thick were prepared using the microtome 
(Microm HM315). 
2.6 Histological Analysis:  
For histological analysis, embryos were dissected at desired stages from timed 




ethanol series, embedded in paraffin as mentioned in the previous section. Before 
proceeding to the staining protocol, samples were first deparaffinized in the oven 
at 58°C for 30 min. Following deparaffinization, the samples were then rehydrated 
through xylene (Fisher Scientific, Waltham, Massachusetts, USA) and a graded 
ethanol series (EtOH) (IBI Scientific, Biotechnology grade) at room temperature in 
the following sequence: immerse the slides in xylene for 10 minutes twice, then 
100% EtOH for 10 minutes twice, then 95% EtOH for 2 minute once, then 70% 
EtOH for 2 minutes once, and finally in PBS for 1 minute twice. Next, slides were 
immersed in hematoxylin stain (Modified Harris Hematoxylin, Sigma-54 
Aldrich,  St. Louis, MO, USA) for 8 minutes. The slides were then placed under 
running water for 5 minutes, following which they were transferred to acid alcohol 
for 30 seconds. The slides were once again shown in running tap water for 2 
minutes and then transferred to lithium carbonate for 45 seconds. The slides were 
washed again in running tap water for 5 minutes. Next, the slides were dipped in 
80% EtoH 10 times and then stained with eosin for 40 seconds. Slides were 
dehydrated through graded ethanol (EtOH) series and xylene at room temperature 
in a fume hood in the following sequence: then 95% EtOH for 5 minutes, then 
100% EtOH for 10 minutes twice, then Xylene for 10 minutes and then in a new 
xylene for 10 minutes. After that sufficient amount of xylene based permount media 
was placed on each slide, and a coverslip was mounted. The slides were then 





2.7 BrdU Assay 
To understand mechanistic role of RA deficiency in cleft palate, we analyzed cell 
proliferation by BrdU incorporation, pregnant females at E12.5 were injected BrdU 
(100mg/kg, Sigma Aldrich) intraperitoneally. After 3 Hours, the embryos were 
harvested, decapitated and the heads were fixed in 4% PFA for 24 hours. The 
heads were then dehydrated through series of ethanol changes and embedded in 
paraffin for sectioning by routine procedures. For BrdU assay, these sections were 
deparaffinized and rehydrated through series of ethanol and PBS. Antigenic heat 
retrieval was performed using citric acid buffer solution. A 2L beaker was taken 
containing 450 mL of freshly prepared citric acid buffer solution adjusted to a PH 
of 6. Temperature of the solution was adjusted to 68 0C. Slides were placed in this 
solution for 15 minutes. Following that, the entire apparatus was cooled down on 
bench for 15 minutes. Slides were then immersed in PBS briefly. Pretreatment with 
2N hydrochloric acid at 370C was then performed for 15-20 minutes in a coplin jar. 
The slides were placed in the coplin jar and were washed in PBS twice for 10 
minutes each on a rotating platform. After permeabilization, specimens were 
blocked in 0.1M Trish Ph7.5, 0.15M NaCl with PE (Perkin-Elmer FP1020) was 
done for at least one hour. The sections were then incubated in 1:100 dilutions of 
anti-BrdU antibody (ab6326, Abcam) diluted with the same blocking agent 
overnight (250 µl of solution per slide). Following primary antibody, samples were 
washed using 0.1% Triton in PBS twice for 10 minutes each. Secondary antibody 
was then used. The secondary antibody that was used to visualize the 




diluted 1 to 300 in block and incubated for 60 minutes. Following the secondary 
antibody, samples were washed with 0.1% Triton in PBS twice for 15 minutes each 
and counter stained with DAPI 1: 1000 dilutions in PBS. The samples were dried 
moderately using Kim wipe and cover slipped using 40 µl of Prolong Gold. The 
percentage of BrdU positive cells to total mesenchymal cells in a fixed area was 
counted in the anterior and mid regions of palate shelves at E12.5. For the analysis 
of bend region, the total number of BrdU positive cells was also counted in a fixed 
rectangular area. Three samples and six palates were examined in each group 
and stage. The percent BrdU positive cells in the palatal mesenchyme of middle 
palate region and the BrdU positive cells per fixed box of the anterior palatal bend 
region were noted in the controls and the Rdh10 conditional mutants and a 
student’s t-test with unequal variance (two tailed) was performed to assess any 
significant differences between the control and the Rdh10 conditional mutants. 
 
2.8 Tongue Measurements: 
The E14.5 embryonic heads (n=3) for each genotype were fixed in 4% PFA, 
embedded in paraffin and were sectioned in the coronal plane at 8 µm thickness. 
Control littermates and Rdh10 conditional mutants were processed in parallel and 
used for comparison. Identical sections in the mid regions of the palate were 
compared between the control and the mutant taken at the same magnification 
using the Axiocam MRC5 microscope. Images were collected from the controls 
and the mutants and measurements were done using Image J. Prior to measuring, 




one sulcus to another. A perpendicular line was then drawn from the tip of the 
tongue to the line previously drawn. This perpendicular representing the height of 
tongue was measured and noted down. Statistical analysis was performed using 
Excel and a paired t test was performed. Statistical significance was determined 
at 90% confidence interval. 
2.9 Roller Bottle Culture for Maxillary Explants: 
Freshly dissected maxillary explants of E13.5 embryos were cultured as described 
previously by Lan et al(Lan, Zhang et al. 2016).  
We performed two different sets of culture experiment. During our initial analysis, 
three to four maxillary explants were placed in each scintillation vial containing 6ml 
BGJb medium (Invitrogen) supplemented with 2.8 mg/ml glutamine, 6mg/ml BSA 
and 1% Penicillin and Streptomycin. The bottle was flushed two minutes each day 
with a gas mixture (50% O2, 45% N2 and 5% CO2), sealed airtight using a silicone 
plug and incubated at 37°C on a Wheaton Mini Bench-Top roller bottle system at 
a speed of 25 rpm for three days. A small piece of tissue was taken from each 
explant after 3 days for genotyping and explants were fixed individually. For 
imaging the palate shelves, these explants were then transferred to 1: 1000 dilution 
of DAPI in PBS and imaged using Leica M165FC Microscope. As we cultured 4 to 
5 maxillae in the same scintillation vial without knowing the genotyping, we called 
this a combo culture.  
In single/ monoculture experiment, we identified the mutants based on salivary 




unable to identify mutants and controls prior to culturing, we cultured single maxilla 
individual vials and the bottles were numbered. We number the tail samples from 
the embryo in the same way sent them genotyping. We followed the same culture 
technique that was followed for the combo culture. Chi Square test was performed 
to analyze statistical significance. 
2.10 Statistical Analysis 
All results were presented as mean ± SEM. All statistical analyses were done using 
Excel software. Two-tailed Student’s t tests were used for comparisons between 
two groups. P value less than 0.05 was considered significant. For tongue 













CHAPTER 3: RESULTS 
3.1 Generation of conditional Rdh10 mutant embryos and heterozygous controls 
In order to generate conditional mutants, we paired Rdh10 flox/flox Ert2Cre2+/+ with 
the Rdh10 -/+. The inducible cre-lox system was used to provide timed excision of 
the Rdh10 gene. The mutants obtained by the genetic cross (Fig. 4) are the 
 Rdh10 flox/-Ert2 Cre and the controls are the heterozygous Rdh10 flox/+ Ert2Cre. 
This means that the mutants have a normal Rdh10 gene expression until activation 
of the Cre recombinase. This activation of cre enzyme is achieved by the 
administration of tamoxifen. Upon tamoxifen administration, the Cre that is bound 
to the ER receptor in the cytoplasm is released into the nucleus. This causes the 
excision of the exon 2 segment of the Rdh10 gene flanked by the LoxP sites. 
The excision causes inactivation of the Rdh10 gene (Fig 5). 
 
This genetic cross is highly useful as we obtain both the heterozygous control 
embryos and the Rdh10 conditional mutant embryos from the same litter. Based 
on our genetic cross, we expect 50% of the embryos from each liter to be controls 
and 50% to be mutants. This genetic cross reduces the variability and prevent bias 
of the experimental set up.  For example with this study design we ensure that 
control embryos and the mutant embryos receive the same dose of tamoxifen, at 
the same time, and are collected at the same developmental stage.  This can only 




In conclusion, we were successful in creating Rdh10 conditional mutants and these 
mutants were used to examine if loss of RDH10 caused cleft palate. 
 
 
Figure 4. Generation of Rdh10 Conditional Mutants Embryos 


















3.2 Conditional Inactivation of Rdh10 causes Cleft palate 
In order to determine if conditional inactivation of Rdh10 causes cleft palate, we 
performed a stage specific excision of Rdh10 by tamoxifen induced conditional 
inactivation. 
 
Even though we know tamoxifen, induced conditional inactivation of Rdh10 can be 
performed, we did not know the optimal timing to administer tamoxifen and how 
long it takes to excise Rdh10.  Therefore, we administered a single dose of 
tamoxifen to pregnant female mice at four different stages prior to palate formation 
and assessed the impact on palate formation in embryos.  Tamoxifen was 
administered either at gestational age at E7.5, or E8.5, or E9.5 or E10.5 and 
harvested embryos at E16.5 to assess palate formation. 
 
Following euthanasia of the tamoxifen-treated pregnant female mouse, embryos 
were isolated, decapitated and fixed in 4% paraformaldehyde. After fixation, the 
mandibles were removed from the embryonic heads allowing us to visualize the 
palate. Using nuclear florescent imaging technique, we captured and analyzed 
images of the palate shelves in control and mutant embryos. 100% of the control 
embryos showed normal palate morphology upon administration of tamoxifen at 
either E7.5, E8.5, E 9.5, or E10.5 (Fig. 6A). Interestingly, the Rdh10 conditional 
mutants showed cleft palate at different stages of tamoxifen administration (Fig 6 
B-E). 
When tamoxifen was administered at E7.5, 9% of the mutant embryos showed 




secondary palate, we also observed 19% of the mutants with minor palate 
abnormalities such as unilateral/ bilateral posterior truncation and incomplete cleft 
of the secondary palate (Fig. 6D, Fig. 7). In addition to the defects mentioned 
above, when tamoxifen was administered at E7.5 we also observed fewer mutants 
than heterozygous controls, indicating that inactivation of Rdh10 caused 
embryonic lethality. We estimate that loss of Rdh10 by tamoxifen administration at 
E7.5 resulted in lethality of 24% of mutant embryos prior to E16.5 (table 3). This is 
likely due to the fact that RA produced by RDH10 activity is not only important for 
the development of the palate, but also for the development of vital organs such 
as the heart. Due to this reason, early knockout of Rdh10 may have caused 
embryonic death.  
In contrast, when we administered tamoxifen at E8.5, we observed a higher 
percentage of palate abnormalities (58%) and we did not see any mutant lethality 
(Fig. 7, table 3).Following administration of tamoxifen at E8.5, mutants were 
obtained at the expected frequency of 50%, indicating that there was no embryo 
lethality at this stage.  Of the mutant embryos 44% showed complete cleft of the 
secondary palate and an additional 14% showed minor palate abnormalities (Fig. 
6E, Fig. 7, table 3).   
The frequency of palate abnormalities was reduced when tamoxifen was 
administered at later stages. When tamoxifen was administered at E9.5, we 
observed 21% of the mutants with complete cleft of the secondary palate (Fig. 7, 
table 3). The percentage of minor palate abnormalities was 32%. The frequency 




other stages of tamoxifen administration. No mutant lethality was noted at this 
stage. 
No palate abnormalities were observed in the mutants when tamoxifen was 
administered at E10.5 (table 3).  We did observe some embryo lethality at this 
stage. However, the percentage embryo lethality and phenotype may not be 
significant owing to the small sample size analyzed. 
From the above results, we can conclude that the highest percentage of cleft palate 
with minimal mutant lethality was observed upon administration of tamoxifen at 
E8.5. Hence, further experiments to understand the mechanistic role of Rdh10 
deficiency in the development of cleft palate was done by administering tamoxifen 
at E8.5.  
In summary, loss of Rdh10 causes cleft palate. When 100% of the controls show 
normal palate phenotype at E16.5, 44% of the mutants show complete cleft palate 
when tamoxifen is administered at E8.5. Therefore, we show that conditional 
inactivation model serves to be an effective way to understand how RA deficiency 
affects palate development 
In addition to establishing a model system that will allow us to improve our 
knowledge on how RA deficiency affects palate development, the results obtained 
from this experiment also hints at the time frame when RA maybe needed during 
palate development.  Early administration of tamoxifen at E7.5 caused mutant 
lethality while later stages of administration (E9.5 and E10.5) showed reduced 




may be needed during specific time frame at early stages of palate development. 
This finding directed our next set of experiments towards understanding the role 




















Figure 6. Morphological analysis of Rdh10 mutant maxilla. Nuclear florescent imaging of E16.5 
control(A) and mutants (B-E). (B) showing complete cleft of the secondary palate in mutant. (C), 
(D), & (E) showing minor palate abnormalities. Arrow in (C) shows a bilateral posterior truncation 
seen in the soft palate. Arrow in (D) shows a unilateral posterior truncation seen in the soft palate. 
Arrows in (E) show an incomplete posterior cleft extending into the hard and the soft palate.(F-I) 
showing a closer version of the defects (B-E) 
 
 





Figure 7. Percent cleft palate distribution and embryo viability at different stages of tamoxifen 
administration. 24% of mutant lethality is seen when tamoxifen was administered at E7.5. 
Tamoxifen administered at stage E8.5 showed maximum percentage of cleft – 59% of the mutants 
examined at E8.5 showed some defects in secondary palate formation. Of the 59% 44% of the 
mutants showed complete secondary palate cleft and 15% showed minor palate abnormalities. As 
we administered tamoxifen later during embryonic development (T9.5, T10.5), we see a fewer 
percentage of cleft to almost no palate abnormalities when tamoxifen is administered at E10.5. This 
gradual reduction in phenotype with progression in stage of administration likely suggest an early 















Table 3. Distribution of embryo genotype that we expected and obtained at different stages of 
tamoxifen administration. We note that the total number of mutants that was expected at E7.5 is 
more than the mutants obtained. According to our genetic cross, we need to get 50% of 
heterozygous controls and mutants per litter. However, since the number of mutants obtained 
was less than the expected, early administration of tamoxifen at E7.5 might have caused some 
mutant lethality. Even though the number of mutants observed at E10.5 is also less, this may be 
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3.3 RA Signaling in the Palate at E12.5: 
Previous studies of RA activity in developing facial tissues have not identified 
active signaling within the palate.  From result 3.2, it is clear that RA is needed for 
palate development. In other words, loss of RDH10-mediated RA production leads 
to cleft palate. In order for us to understand the possible mechanistic role of RA 
during the development of palate, we wanted to see if there is any detectable RA 
signaling within the developing palate shelves. The RARE-Lac Z reporter mouse 
was used to understand the spatiotemporal distribution of RA within the palate 
shelves. The RARE-LacZ reporter mouse line was generated by Rossant et al 
(Add reference!),in which bacterial LacZ gene was placed under the RA receptor 
element. Detection of the reporter gene expression is identified dark blue X-gal 
stainwhich indicates cells that have active RA signaling. In order to examine if RA 
signaling activity was present in developing palate shelves we harvested 
RARE-LacZ embryos at E12.5 when early palate shelf growth occurs. We exposed 
the palate by removing the mandible and tongue and performed X-gal staining. 
This helped us capture even the weakest RA signaling within the palate shelves.  
The whole mount images of the LacZ stained embryos revealed strong RA 
signaling in the developing nasal sinus region and the primary palate. Careful 
examination of the secondary palate revealed a small patch of signaling in the 
anterior-most region of the developing palate shelves (Fig. 8). The precise tissue 
distribution of the RA signaling was analyzed by paraffin sectioning of the whole-





Consistent with previous studies, no RA signaling activity was detected in the 
posterior or middle palate shelf tissue (Fig 9 A, B).  However, careful histological 
analysis reveals for the first time that RA signaling is present in the developing 
secondary palate at E12.5. RA signaling was seen in the epithelium of the bend 
region of the anterior palate shelf and the sub-nares anterior zone (SNAZ) (Fig 9 
C-F). Although RA signaling was detected in the epithelium of the SNAZ and bend 
region, no signaling was detected in the middle palate and the posterior palate 
regions. We also did not detect any signaling in the mesenchyme of the palate 
shelf at any regions at E12.5. 
This finding is extremely valuable in our field of study. Not only has there been a 
gap in knowledge regarding the role of RA in palate development, but also no 
reported finding of RA signaling within the palate shelf tissues (Okano, Kimura et 
al. 2012).  
Collectively, these data suggest that RA signaling is seen in the developing palate 
shelf at an appropriate time to play an important role in its development. This RA 
signaling may be an important intrinsic factor essential for normal development of 







                                 
Figure 8. Activity of RARE LacZ in developing secondary palate. Whole Mount ß galactosidase 
staining of developing palate at E12.5 with the tongue and mandible removed. Dark Blue areas 
reveal RAR activity (A). We can see strong signaling in the developing primary palate and the 
nasal sinus region. The red line depicts the palate shelf outline on the left side. Since signaling in 
sinus is very strong, it is difficult to identify signaling in the anterior region of the palate shelf 























Figure 9. Histological sections stained with nuclear fast red showing RARE LacZ activity. Frontal sections 
showing the posterior part of the palatal shelf (A), middle part of the palatal shelf(B), anterior part of the 
palatal shelf(C) and the sub nares anterior zone(SNAZ) (D) of the developing secondary palate at E12.5 
taken at 4X magnification. Although some RA signaling activity is seen the corner of the mouth in the 
posterior region and the middle region of the palatal shelves at E12.5, no detectable signaling seen in 
the palatal shelf epithelium or mesenchyme in these regions (A&B). E&F are the same sections as C&D 
taken at 10X magnification.10X view of the anterior region showing RA activity in the bend region of the 
palate (E).10X view of the SNAZ region of the developing secondary palate showing RA signaling activity 
within the epithelium of the palate shelf. (F). Arrow indicates RA signaling in the epithelium of developing 
palate shelf tissues. No signaling detected in the mesenchyme at this stage. CM- corner of the mouth; 











3.4 Rdh10 conditional mutants not only display intrinsic defects in early palate 
morphogenesis, but also extrinsic defects in tongue positioning.  
 Now that we have a model system that allows us to study the role of endogenous 
RA, we can try to understand the underlying mechanisms it regulates in the palate. 
Palate development, as described above (Fig. 2), is a sequential process that 
occurs beginning early E11.5 up to E16.5. Since we see cleft palate in Rdh10 
conditional mutant embryos at E16.5 by whole mount imaging (Fig. 6 B-E), we 
examine the palate tissues of control and mutant embryos by histological staining 
at E16.5.  
Histological sections taken at E16.5 of the heterozygous controls and the Rdh10 
conditional mutants is shown in Fig 10 A-D. Inadequate growth and improper 
elevation of palate shelf tissue along with abnormal positioning of the tongue are 
some of the findings in the mutants compared to the controls. Growth and elevation 
of palate shelf tissues are early events that occur during secondary palate 
development. The defects seen at E16.5 are defects that must have occurred 
during early stages of palate development. These early defects along with early 
RA signaling seen at E12.5 (Result 3.2) once again suggest an early role of RA 
during palate development. All our previous results have suggested a possible role 
of RA in early palate morphogenesis. Therefore, in order to understand the 
mechanism of palate defects resulting from loss of Rdh10, we examined embryos 
at different early stages of palatogenesis i.e. E12.5, E13.5 and E14.5 after 




Morphological variations observed using hematoxylin and eosin (H&E) staining 
revealed abnormalities in the palate shelf tissue of mutant embryos as early as 
E12.5. We compared three controls and three mutants at this stage. H& E staining 
of the anterior, middle and the posterior region of the palatal shelves revealed 
shorter palatal shelves in the mutants compared to the control (Fig. 11 A-F). All the 
mutants observed at this stage showed lack of groove between the palate shelf 
tissue and the body of the maxilla in the mid sections of the developing secondary 
palate (Fig. 11 D). Moreover, the palatal shelf outgrowth in the anterior region was 
reduced in the mutants compared to the control (Fig. 11 F). 
Morphological abnormalities were also observed in mutant embryos at E13.5.  
Mutant embryos examined at E13.5 revealed a sharp bend region (Fig 12) 
compared to the more rounded bend morphology of the controls. We examined 
three controls and three mutants at this stage and all three mutants revealed this 
phenotype. 
We also harvested and sectioned embryos at E14.5. Variations in palate shelf 
orientation was observed at this stage in both the controls and the mutants. Of the 
six controls sectioned, three controls showed palate shelves that had elevated and 
contacted in midline, and three showed vertically oriented palate shelves. Of the 
six mutants sectioned, two mutants showed horizontally oriented palate shelves 
contacting in midline, one showed asymmetric elevation of palate shelf and 3 




We wanted to compare the tongue height in Rdh10 conditional mutants and the 
controls that had a vertically oriented palate shelf at E14.5. We looked at the mid 
palate sections from three controls and three mutants. We found that Rdh10 
conditional mutants showed taller tongue compared to controls (Fig 13 and table 
4). Statistical significance was obtained at p<0.1.  
 In addition to the taller tongue at E14.5, we also noted abnormal fusion between 
the mandible and the palatal shelf in two of the three mutants examined. Abnormal 
shelf-to-mandible contact and loss of epithelium in the developing mandible and 
palate was noted with mesenchymal cell fusion (Fig.14). Abnormal shelf-to-
mandible contact may cause cleft palate by preventing the elevation of palate 
shelves. However, our mutants that showed such fusion in the posterior region of 
the developing palate shelves showed palatal shelves contacting at the midline in 
the anterior and middle region. This observation suggest that, abnormal shelf- 
mandible fusion may result in minor palate abnormalities and not be directly 
involved in causing cleft palate in Rdh10 conditional mutants. 
In summary, defects in early palate morphogenesis are detected in Rdh10 
conditional mutant embryos. Abnormalities in palate morphology can be seen as 
early as E12.5. Rdh10 mutants show sharp bend regions at E12.5 and taller 
tongues and shelf-to-mandible fusion at E14.5. The presence of RA signaling 
within palate shelf tissues (Fig. 9) and the defects in early palate shelf morphology 
suggest that the loss of Rdh10 could cause cleft palate by a mechanism intrinsic 
to the palate shelf tissues.  However, we cannot eliminate the fact that we also see 




cause cleft palate by a mechanism extrinsic to the palate shelf tissues if the 















































Figure 10. Morphological and histological comparison of control and Rdh10 conditional 
mutant at E16.5. Nuclear florescent image of palate of control (A) and Rdh10 conditional 
mutants. (B)The red line on DAPI images (A&B) showing the location of palate of H&E 
stained coronal sections from the control (C) and the Rdh10 conditional mutants(D) at 
embryonic age E16.5 (D) showing inadequate growth and improper elevation of palate 





























Figure 11.Rdh10 conditional mutants showed morphological defects in palate shelves as early 
as E12.5. Hematoxylin and Eosin stained coronal sections of E12.5 control and Rdh10 conditional 
mutant embryos. (A-F). Shorter palate shelves in posterior region seen in Rdh10 conditional 
mutants (B) compared to control littermates (A). Lack of mid palate groove between the palate 
shelf and body of maxilla also seen in mutants (D) compared to control(C) in the mid palate 
region. Reduced palate shelf outgrowth seen in the Rdh10 conditional mutants (F) compared to 
controls in the anterior region of palate shelves. Arrow indicates region of defect.PS- Palatal shelf; 





Figure 12.Rdh10 conditional mutants display a sharp bend region at E13.5. Coronal sections of 
E13.5 showing the posterior palate shelves in the control (A) and Rdh10 Conditional mutants (B) 
Arrows indicate the bend region. Three of the three mutants examined showed this abnormality 














Figure 13.Rdh10 conditional mutants show taller tongue. (A) Shows heterozygous control and (B) 
represents Rdh10 conditional mutant. Measurement of tongue height were compared as 
demonstrated by the black line in A & B (n=3). Statistical significance is denoted by the * over the 
















t-Test: Two-Sample Assuming Unequal Variances 
     
  Controls Mutants   
Mean 0.601667 0.690667   
Variance 0.002382 0.00027   
Observations 3 3   
Hypothesized Mean 
Difference 0    
df 2    
t Stat -2.99302    
P(T<=t) one-tail 0.047925    
t Critical one-tail 2.919986    
P(T<=t) two-tail 0.09585    
t Critical two-tail 4.302653     
 
Table 4. T test table for height of tongue. The first table representing raw data obtained. 
Measurements shown are in mm and was obtained using Image J. t test assuming unequal 






Height of Tongue(in mm) 
Control 1 0.608 
 
Control 2 0.647 
 




   
Mutant 1 0.703 
 
Mutant 2 0.672 
 
























Control Rdh10 Conditional Mutants 
A B 
Figure 14.Rdh10 conditional mutations show palate-oral fusion compared to controls at E14.5. 
Coronal H& E sections through E14.5 control (A) and Rdh10 Conditional mutant (B) littermates in 




3.5 Increased Defects in Proliferation of Palatal Mesenchyme seen at E12.5: 
To investigate the intrinsic role of RA in cleft palate, we examined cell turn-over by 
BrdU incorporation. We chose to study cell proliferation over other cellular 
mechanisms that could be altered because excess RA has been shown to have 
an effect on cell proliferation in the palate (Okano, Kimura et al. 2012). We wanted 
to see if our Rdh10 conditional mutants showed altered cell proliferation. Because 
we observe RARE-LacZ activity within the developing palate at E12.5, we 
assessed the regulation of cell proliferation in the mesenchyme of palate shelves 
at that stage. Since a clear morphological difference was seen in the anterior and 
mid palate regions in the mutants compared to controls, we decided to measure 
proliferation in these regions. We therefore administered BrdU to tamoxifen-
treated pregnant mice at E12.5.  Embryos were harvested 3 hours after BrdU 
exposure, fixed, sectioned, and immunostained for presence of BrdU incorporated 
into DNA.   
 In order to quantify the percentage of cells within the palate shelves that had 
incorporated BrdU into their DNA, fter immunostaining and imaging, we marked 
the outline of palate shelf outgrowth in both the controls and the mutants using the 
ImageJ software. We then counted the total number of DAPI positive nuclei in the 
mesenchyme and the epithelium of the palate shelf and the total number of BrdU 
positive cells per palate shelf (Table 5 & 6). The ratio of BrdU positive cells to the 
total number of DAPI positive cells was compared between the heterozygous 
controls and the Rdh10 conditional mutants in anterior and mid coronal sections 




conditional mutants with reduced total number of cells, no statistical difference was 
noted in percent of BrdU positive cells in the mesenchyme of the palate shelves.  
We also wanted to see if there was any difference in proliferation at the bend region 
where RA signaling is seen. We therefore outlined a fixed-size box in the bend 
region of control and mutant embryo images and counted the total number of BrdU 
positive cells per fixed box. The proliferation in the proximal bend region of the 
palate shelf was significantly increased in the Rdh10 conditional mutants 




















































212 105 49.5283019 
   
























103 42 40.776699 
   
Avg= 43.1690058 






























































250 74 29.6 
   
























198 84 42.4242424 





t-Test: Two-Sample Assuming Unequal Variances-SNAZ 
Mesenchyme      
  Control Mutants 
  
Mean 44.67747 43.16901 
  
Variance 13.14854 24.88805 
  





   
df 9 
   
t Stat 0.599113 
   
P(T<=t) one-tail 0.281936 
   
t Critical one-tail 1.833113 
   
P(T<=t) two-tail 0.563872 
   










Table 7. Analysis of lack of significance of percentage of BrdU-positive proliferating cells in 
anterior and mid-palate mesenchyme. Student t test assuming unequal variance was completed 
for three samples each from control and Rdh10 conditional mutants. Observations are shown as 
six as it includes right and left shelf from three different samples. P values obtained is more than 
0.05, allowing us to conclude that there is no difference in percent of BrdU positive cells between 
the control and the Rdh10 conditional mutants in both the mid palate and SNAZ mesenchyme. 
 
t-Test: Two-Sample Assuming Unequal Variances- Mid 
Palate Mesenchyme      
  Control Mutants 
  
Mean 28.3015 36.64037 
  
Variance 11.20374 114.3917 
  





   
df 6 
   
t Stat -1.82262 
   
P(T<=t) one-tail 0.059095 
   
t Critical one-tail 1.94318 
   
P(T<=t) two-tail 0.118191 
   
t Critical two-tail 2.446912   
  





t-Test: Two-Sample Assuming Unequal Variances 
Total Proliferating Cells in SNAZ mesenchyme 
  Control Mutants 
  
Mean 80.66667 45.33333 
  
Variance 389.0667 99.86667 
  





   
df 7 
   
t Stat 3.914132 
   
P(T<=t) one-tail 0.002896 
   
t Critical one-tail 1.894579 
   
P(T<=t) two-tail 0.005793 
   
t Critical two-tail 2.364624   
  
 
t-Test: Two-Sample Assuming Unequal Variances 
Total Proliferating Cells in Mid-Palate Mesenchyme 
  Controls Mutants 
  
Mean 85.16667 83.83333 
  
Variance 125.7667 91.36667 
  





   
df 10 
   
t Stat 0.221642 
   
P(T<=t) one-tail 0.414527 
   
t Critical one-tail 1.812461 
   
P(T<=t) two-tail 0.829054 
   
t Critical two-tail 2.228139   
  
     
     
Table 8. Analysis of significant difference seen in the total proliferating cells in the anterior 
mesenchyme. No significance in proliferating cells seen in mid palate mesenchyme  Student t test 
assuming unequal variance was completed for three samples each from control and Rdh10 
conditional mutants. Observations are shown as six as it includes right and left shelf from three 
different samples. P values obtained is less than 0.05, allowing us to conclude that the total 
proliferating cells in the palate mesenchyme at SNAZ region was fewer in mutants compared to 





Figure 15.Comparison of proliferating cells and percent BrdU positive cells between control 
littermates and Rdh10 conditional mutants in the palatal mesenchyme of the SNAZ region and mid 
palate region of palate shelves. DAPI images of the coronal sections from the control littermate (A) 
and Rdh10 conditional mutant (B) taken in a 4X magnification that were compared in the SNAZ 
region. DAPI images of the coronal sections from the control littermate(C) and Rdh10 conditional 
mutant (D) taken in a 4X magnification that were compared in the mid palate region. Yellow line 
indicates the outer border of palatal shelf up to which cell counting was made. Graphical 
representation of the percent BrdU positive cells in these regions in the control and Rdh10 
conditional mutants shown in fig (I) Graphical representation of the number of BrdU positive cells 
per palate shelf in the SNAZ and mid palate mesenchyme in these regions in the control and Rdh10 
conditional mutants shown in fig (J). Three sections from the wild type and the mutant were 
compared. P<0.05 was considered statistically significant. Error bard represent Stdev. * indicates 
significance. PM- Palatal Mesenchyme. 
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Figure 16.Rdh10 conditional mutants show an increase in cell proliferation at the bend region in 
the mesenchyme of anterior palate shelf at E12.5. (A) and (B) showing 4x Hematoxylin and Eosin 
coronal section of the anterior region of palate shelf at E12.5. Black box indicates 4x view of 
image (C) and (D). (C) and (D) represents immunofluorescence staining. Red cells indicating 
BrdU positive cells. Proliferating cells in bend region counted per fixed box as outlined by the 
yellow rectangles in (C) and (D). (E) represents the graphical presentation of the values obtained. 













3.6 Ex-Vivo Culture of Isolated Maxilla Suggest an Extrinsic Role for RDH10 
during Palate Development 
Although cell proliferation assay suggests an intrinsic defect within the palate shelf 
with increased cell proliferation in the bend region in the mutants compared to the 
controls, it is possible that the failure of palate shelf elevation could be secondary 
to defects in abnormal tongue and mandible. To investigate this possibility, we 
performed a 36 hours’ suspension culture of the maxilla with mandible and tongue 
removed. 
Control and mutant embryos were harvested at E13.5 after administration of 
tamoxifen at E8.5. The heads were separated from the body. The maxillae were 
isolated from remaining part of the head by removal of the mandible, forebrain, 
and hindbrain. The micro dissected maxillary explants were then suspended in 
culture containing modified BGJb medium for 3 days as described in chapter 2. 
Since we did not know the genotype of the embryos, initial experiments were 
carried out by culturing 3 to 4 maxilla’s together in each scintillation vial, and a 
small piece of tissue was removed after culture for genotyping purposed. We 
named this type of culture as a “combo” culture. The Vials were gassed with 50% 
O2, 5% CO2, and balance N2 each day for two minutes. Genotyping was done after 
completion of the culture experiment. The maxillae were fixed and imaged using 
the pseudo SEM method described previously. 
The results that we obtained from the first combo culture is depicted in Fig.17. The 
fusion rate of palate shelves observed in the mutants was more than that of the 




controls in the same vial. Cleft palate was seen in controls that were grown 
together with these mutants. No cleft palate was observed in controls that were 
cultured with other control maxillae in the same vial. Moreover, all mutants that 
were cultured together in the same vial showed cleft palate. These initial results 
led us to speculate that when control maxillae are cultured with mutants, it is 
possible that the RA produced in the controls can cross from one tissue to the 
other to help in the growth of palate shelves in mutants.  
To test this hypothesis, we decided to perform a “monoculture” whereby maxillae 
of mutant embryos were cultured in vials separate from controls. Sometimes, we 
were able to predict the genotype of the mutant embryos based on their small 
salivary gland phenotype or a characteristic branching defect in mutant lungs. In 
such cases, 2-4 mutant maxilla were suspended together in each vial, and the 
controls in different vials. In other cases, we culture each individual maxilla in an 
independent vial.  In a total of seven monoculture experiments, the incidence of 
cleft palate that we observed in the mutants was 22.83% and that in the controls 
was 12.50% (Fig 18). These data indicate that mutant palates fuse at a frequency 
similar to controls when cultured ex vivo without mandible and tongue.  
In order to determine if the fused mutant cultured maxillae had evidence of sub 
mucous cleft or other histological defects, we processed three controls and three 
mutants from three different culture experiments for histological examination. On 
examination of the H & E stained sections, we observed that of the three-control 
culture maxilla, two-showed incomplete fusion with remaining midline epithelial 




three mutants showed complete fusion and one showed incomplete fusion with 
remaining midline epithelial seam. Comparing these findings, we can say that no 
significant difference in midline fusion was seen in the Rdh10 conditional mutants 
compared to the heterozygous controls after 72 hours’ culture. 
These results suggest that the cleft of the secondary palate seen in RA deficiency 
is predominantly due to an extrinsic defect in either the mandible development or 


























 CONTROL 6 3 50% 
 MUTANTS 6 4 66.67% 
    
 
 
   
Figure 17. Graphical representation of the fusion rates of palate shelves in the controls and the 
Rdh10 conditional mutants in combo culture. With our preliminary data, we concluded that the RA 
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 CONTROL 16 14 87.50% 
MUTANTS 22 17 77.27% 
Figure 18.Graphical representation of the fusion rates of palate shelves in the controls and the 
Rdh10 conditional mutants obtained in monoculture. Even though it appears that the fusion rate 
of palate shelves in mutants is fewer than the controls, no statistical difference is observed 
compared to controls. This data suggests that removal of tongue and the mandible rescues cleft 






Figure 19.Comparison of histological sections of controls and Rdh10 conditional mutants after 72 
hours in culture. (A) and (B) showing nuclear florescent imaging of the palate shelf. C-F showing 
histological coronal paraffin sections of the cultured maxilla. Three controls and three mutant 
samples from three litters were sectioned and stained by hematoxylin and eosin staining. One of 














fusion (D). Two controls showed incomplete fusion (E) in comparison to one mutant that showed 














3.7 Ectopic Fusion in Nasal Region seen in Rdh10 Conditional Mutants:  
Previous studies have shown that Rdh10 conditional mutants exhibit choanal 
stenosis or nasal obstruction when we administer tamoxifen at gestational age 
E7.5(Kurosaka, Wang et al. 2017). The mutants reported in this study were slightly 
different in breeding. They contained only one pair of flox allele while our mutants 
contain two pair of flox allele. Hence, we could expect the kinetics of tamoxifen 
excision to be slightly different in both cases. We still wanted to see if we see any 
similar phenotype in our mutants. Hence, we decided to analyze the sections that 
were stained by hematoxylin and eosin for nasal obstruction. Although not as 
severe as previously reported by Kurosaka et al, we did observe the nasal 
obstruction phenotype when we administered tamoxifen at either E7.5 or E8.5.  At 
E12.5, apart from the abnormalities in palate morphology, we also detected a 
shorter, wider and obliterated sinus opening in two of the three mutants in the 
SNAZ where RA signaling is seen. Embryos harvested at E13.5 showed an ectopic 
fusion between the nasal septum and the medial nasal epithelium. 73% of the 







































































Figure 20.Nasal obstruction and ectopic fusions seen in Rdh10 conditional mutants. Coronal H & 
E sections through the nasal region at stages E12.5, E13.5, E14.5, & E15.5 (A-H). Rdh10 
conditional mutants show shorter, wider and obliterated sinus at E12.5 (B) compared to controls 
(A). At E13.5, controls showed a clear sinus tract(C) while Rdh10 conditional mutants showed 
fusion between the developing nasal sinus and the medial nasal epithelium. At E14.5, mutants 
showed obliterated nasal sinus region (F) compared to controls at this stage (E). At E15.5, complete 

















CHAPTER 4: DISCUSSION 
The association of cleft palate with lack of Vitamin A/ RA in diet has been known 
for 80 years now but the mechanisms underlying this defect is unknown. One of 
the main reasons for the gap in knowledge of how deficient RA affects palate 
development is due to a lack of a model system to study its function at palate 
developmental stages. In this study, we have addressed this major gap in 
knowledge of how RA deficiency affects the development of palate by establishing 
a model system that will allow us to further investigate the role of RDH10 mediated 
metabolism of vitamin A in palate development. We did this by inactivating RDH10, 
a critical enzyme that catalyzes the first step in the conversion of Vitamin A into its 
active form, RA. We observed 100% of control embryos had fusion of palate shelf 
at E16.5, while 44% RA deficient mutant embryos had complete cleft of the 
secondary palate. 
In our study, administering tamoxifen at different gestational periods before palate 
initiation also proved to be useful in understanding the period when endogenous 
RA is needed for palate development. Administration of tamoxifen at early 
gestational age E7.5 caused higher percentage of mutant lethality and later stages 
of administration at E10.5 showed normal phenotype. This observation suggests 
that RDH10 mediated metabolism of RA maybe needed during a specific time 




Previous studies show that there is no RA signaling within the developing 
palate.(Okano, Kimura et al. 2012).  However, for the very first time, using RARE-
LacZ mice, we have shown RA signaling within the developing palate shelves at 
embryonic age E12.5.  This difference in the result obtained could be due to a 
variation in the way the experiment was carried out. Removal of the tongue and 
the mandible allowed better penetration of the X-gal staining and capturing most 
of the RA activity in the developing palate shelves at E12.5.  
The finding that Rdh10 inactivation causes cleft palate and the presence of RA 
signaling within the developing palate shelf tissue at E12.5 raised a question of 
what mechanisms RA regulates in the developing palate. Interestingly, even 
though we detect RA signaling within palate shelf tissues and an increase in cell 
proliferation at the bend region in E12.5, the cleft palate seen in RA deficient 
mutants was not due to an intrinsic defect in the palate shelf itself. Our study 
demonstrates that the cleft palate seen in RA deficiency is secondary to abnormal 
tongue and mandible development in Rdh10 mutants. We have come to this 
conclusion based on the ex vivo maxillary explant culture experiment and the 
measurement of tongue height from histological sections at E14.5. Cleft palate 
seen in Rdh10 mutants was rescued upon culturing maxilla independent of tongue 
and mandible. 
Our data put together provide us with useful insights on the role on endogenous 
RA in palate development. Our results demonstrate a predominant non-intrinsic 




In contrast to the gap in knowledge of RA deficient cleft palate, the teratogenic 
effects of excess RA is well known. From published literature, we know that excess 
dosage of RA can also cause cleft palate. Comparing the findings of our study of 
RA deficiency with other published studies on RA excess, it is clear that the 
mechanisms underlying the two are quite different. 
In conclusion, the RA deficient model of cleft palate needs further investigation. 
The findings from my thesis work further directs our research work to mandibular 
and tongue abnormalities that may be caused due to RA deficiency. Small 
mandible, difficulty in respiration due to glossoptosis and cleft palate are features 
of a serious syndrome called the Pierre Robin Sequence. The primary data 
obtained in my research work suggest a possibility of RA deficiency resembling 
the Pierre Robin Sequence. We can confirm this hypothesis by directing future 
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